177 related articles for article (PubMed ID: 27143595)
1. Impact of lipases on the protective effect of SEDDS for incorporated peptide drugs towards intestinal peptidases.
Leonaviciute G; Zupančič O; Prüfert F; Rohrer J; Bernkop-Schnürch A
Int J Pharm; 2016 Jul; 508(1-2):102-8. PubMed ID: 27143595
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the protective effect of self-emulsifying peptide drug delivery systems towards intestinal proteases and glutathione.
Hetényi G; Griesser J; Moser M; Demarne F; Jannin V; Bernkop-Schnürch A
Int J Pharm; 2017 May; 523(1):357-365. PubMed ID: 28347848
[TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin.
Hintzen F; Perera G; Hauptstein S; Müller C; Laffleur F; Bernkop-Schnürch A
Int J Pharm; 2014 Sep; 472(1-2):20-6. PubMed ID: 24879935
[TBL] [Abstract][Full Text] [Related]
4. Development and in vitro characterization of self-emulsifying drug delivery system (SEDDS) for oral opioid peptide delivery.
Zupančič O; Rohrer J; Thanh Lam H; Grießinger JA; Bernkop-Schnürch A
Drug Dev Ind Pharm; 2017 Oct; 43(10):1694-1702. PubMed ID: 28589736
[TBL] [Abstract][Full Text] [Related]
5. Development and in vitro evaluation of an oral SEDDS for desmopressin.
Zupančič O; Leonaviciute G; Lam HT; Partenhauser A; Podričnik S; Bernkop-Schnürch A
Drug Deliv; 2016 Jul; 23(6):2074-83. PubMed ID: 26923905
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of self-emulsifying drug delivery systems for oral insulin delivery using an in vitro model simulating the intestinal proteolysis.
Liu J; Hirschberg C; Fanø M; Mu H; Müllertz A
Eur J Pharm Sci; 2020 Apr; 147():105272. PubMed ID: 32084584
[TBL] [Abstract][Full Text] [Related]
7. Oral self-nanoemulsifying peptide drug delivery systems: impact of lipase on drug release.
Mahjub R; Dorkoosh FA; Rafiee-Tehrani M; Bernkop Schnürch A
J Microencapsul; 2015; 32(4):401-7. PubMed ID: 26052722
[TBL] [Abstract][Full Text] [Related]
8. Development and in vitro characterisation of an oral self-emulsifying delivery system for daptomycin.
Zupančič O; Partenhauser A; Lam HT; Rohrer J; Bernkop-Schnürch A
Eur J Pharm Sci; 2016 Jan; 81():129-36. PubMed ID: 26485536
[TBL] [Abstract][Full Text] [Related]
9. Hydrophobic ion pairing: Key to highly payloaded self-emulsifying peptide drug delivery systems.
Griesser J; Hetényi G; Moser M; Demarne F; Jannin V; Bernkop-Schnürch A
Int J Pharm; 2017 Mar; 520(1-2):267-274. PubMed ID: 28188875
[TBL] [Abstract][Full Text] [Related]
10. Peptide release from SEDDS containing hydrophobic ion pair therapeutic peptides measured by Taylor dispersion analysis.
Chamieh J; Domènech Tarrat A; Doudou C; Jannin V; Demarne F; Cottet H
Int J Pharm; 2019 Mar; 559():228-234. PubMed ID: 30703502
[TBL] [Abstract][Full Text] [Related]
11. Trypsin decorated self-emulsifying drug delivery systems (SEDDS): Key to enhanced mucus permeation.
Shahzadi I; Dizdarević A; Efiana NA; Matuszczak B; Bernkop-Schnürch A
J Colloid Interface Sci; 2018 Dec; 531():253-260. PubMed ID: 30036849
[TBL] [Abstract][Full Text] [Related]
12. Development, in vitro and in vivo evaluation of a self-emulsifying drug delivery system (SEDDS) for oral enoxaparin administration.
Zupančič O; Grieβinger JA; Rohrer J; Pereira de Sousa I; Danninger L; Partenhauser A; Sündermann NE; Laffleur F; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2016 Dec; 109():113-121. PubMed ID: 27693677
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of emulsifiers in sedds on protease activity: Just an illusion?
Lupo N; Fidahic U; Hetényi G; Griesser J; Bernkop-Schnürch A
Int J Pharm; 2017 Jun; 526(1-2):23-30. PubMed ID: 28445766
[TBL] [Abstract][Full Text] [Related]
14. Self-emulsifying drug delivery systems: Impact of stability of hydrophobic ion pairs on drug release.
Nazir I; Asim MH; Dizdarević A; Bernkop-Schnürch A
Int J Pharm; 2019 Apr; 561():197-205. PubMed ID: 30836151
[TBL] [Abstract][Full Text] [Related]
15. Combination of SEDDS and Preactivated Thiomer Technology: Incorporation of a Preactivated Thiolated Amphiphilic Polymer into Self-Emulsifying Delivery Systems.
Hetényi G; Griesser J; Nardin I; Bernkop-Schnürch A
Pharm Res; 2017 Jun; 34(6):1171-1179. PubMed ID: 28283859
[TBL] [Abstract][Full Text] [Related]
16. Enhanced oral bioavailability of piperine by self-emulsifying drug delivery systems: in vitro, in vivo and in situ intestinal permeability studies.
Shao B; Cui C; Ji H; Tang J; Wang Z; Liu H; Qin M; Li X; Wu L
Drug Deliv; 2015; 22(6):740-7. PubMed ID: 24670090
[TBL] [Abstract][Full Text] [Related]
17. A Rundown Through Various Methods Used in the Formulation of Solid Self-Emulsifying Drug Delivery Systems (S-SEDDS).
Almeida SRD; Tippavajhala VK
AAPS PharmSciTech; 2019 Oct; 20(8):323. PubMed ID: 31654184
[TBL] [Abstract][Full Text] [Related]
18. Development and in vitro characterization of an oral self-emulsifying delivery system (SEDDS) for rutin fatty ester with high mucus permeating properties.
Cardona MI; Nguyen Le NM; Zaichik S; Aragón DM; Bernkop-Schnürch A
Int J Pharm; 2019 May; 562():180-186. PubMed ID: 30898639
[TBL] [Abstract][Full Text] [Related]
19. Highly mucus permeating and zeta potential changing self-emulsifying drug delivery systems: A potent gene delivery model for causal treatment of cystic fibrosis.
Griesser J; Hetényi G; Federer C; Steinbring C; Ellemunter H; Niedermayr K; Bernkop-Schnürch A
Int J Pharm; 2019 Feb; 557():124-134. PubMed ID: 30594687
[TBL] [Abstract][Full Text] [Related]
20. Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view.
Chatterjee B; Hamed Almurisi S; Ahmed Mahdi Dukhan A; Mandal UK; Sengupta P
Drug Deliv; 2016 Nov; 23(9):3639-3652. PubMed ID: 27685505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
